Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

COMPUGROUP MEDICAL SOCIETAS EUROPAEA

(COP)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

CompuGroup Medical SE: CompuGroup acquires parts of Cerner's IT Healthcare business in Germany and Spain and prepares the Change of Legal Form into a Partnership Limited by Shares (Kommanditgesellschaft auf Aktien, KGaA)

02/05/2020 | 02:10am EDT

DGAP-Ad-hoc: CompuGroup Medical SE / Key word(s): Takeover/AGM/EGM
CompuGroup Medical SE: CompuGroup acquires parts of Cerner's IT Healthcare business in Germany and Spain and prepares the Change of Legal Form into a Partnership Limited by Shares (Kommanditgesellschaft auf Aktien, KGaA)

05-Feb-2020 / 08:08 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Today, CompuGroup Medical SE and Cerner Corporation have entered into a purchase agreement regarding the acquisition of parts of Cerner's IT Healthcare portfolio in Germany and Spain. The Supervisory Board of CompuGroup has already approved the transaction today.

The key products of the acquired portfolio are "medico" and "Soarian Integrated Care", leading hospital information systems (HIS) in Germany, "Selene", a leading HIS in Spain, and "Soarian Health Archive", a document archiving solution for healthcare providers.

The purchase price amounts to EUR 225 million and is subject to a price adjustment mechanism upon the closing day. For 2019, the revenues of the acquired business were approximately EUR 74 million and had an EBITDA of approximately EUR 13 million. The customer base of the acquired business consists of 251 hospitals in Germany and of 65 hospitals in Spain.

Closing of the transaction is expected for the 3rd quarter of 2020 and is subject to merger control clearance and other closing conditions.

In addition, the Management Board and the Supervisory Board of CompuGroup Medical SE (CGM) have resolved today to propose to the shareholders' meeting of CGM on May 13, 2020 a change of the legal form of the company into a partnership limited by shares (Kommanditgesellschaft auf Aktien, KGaA). The general partner (persönlich haftender Gesellschafter/Komplementär) of the KGaA shall be a monistically structured European Company (SE), which is held directly or indirectly at 100% by the founder of CGM Frank Gotthardt as well as further members of the Gotthardt family and Dr. Reinhard Koop (collectively the majority shareholders of CGM). The change of legal form shall enable the company to obtain the greatest possible flexibility with a view to the financing of future growth and to maintain at the same time with the founding family Gotthardt an anchor shareholder which keeps up the entrepreneurial approach and the founding spirit.

The change of legal form does not change the share that investors own in CompuGroup Medical. They will hold the same number of no-par-value bearer shares in the KGaA as they do in CGM prior to the change of legal form. The aggregate number of no-par-value shares issued remains unchanged.

The Management Board will prepare a conversion report for the resolution proposal, which will be made available to the shareholders together with the invitation. The majority shareholders of CGM, the Gotthardt family together with Dr. Koop, have informed CGM that they support the change of legal form.



Contact:
Claudia Thomé
Head of Investor Relations
CompuGroup Medical SE
email: claudia.thome@cgm.com
phone +49 261 8000 7030
phone +49 261 8000 6200

05-Feb-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: CompuGroup Medical SE
Maria Trost 21
56070 Koblenz
Germany
Phone: +49 (0)261 8000 6200
Fax: +49 (0)261 8000 3200
E-mail: investor@cgm.com
Internet: www.cgm.com
ISIN: DE0005437305
WKN: 543730
Indices: MDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 968249

 
End of Announcement DGAP News Service

968249  05-Feb-2020 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=968249&application_name=news&site_id=zonebourse

© EQS 2020
All news about COMPUGROUP MEDICAL SOCIETAS EUROPAEA
10/15COMPUGROUP MEDICAL : Kepler Cheuvreux sticks Neutral
MD
10/06COMPUGROUP MEDICAL : Raised to Buy by Warburg Research
MD
09/21COMPUGROUP MEDICAL SE & CO. KGAA : Preliminary announcement of the publication of quarterl..
EQ
09/20COMPUGROUP MEDICAL : Deutsche Bank remains its Buy rating
MD
09/16COMPUGROUP MEDICAL : Warburg Research revises his opinion and turns to Neutral
MD
09/15COMPUGROUP MEDICAL : Receives a Sell rating from Baader Bank
MD
09/15COMPUGROUP MEDICAL : Receives a Buy rating from Warburg Research
MD
09/15COMPUGROUP MEDICAL : Gets a Sell rating from Baader Bank
MD
09/14COMPUGROUP MEDICAL : Receives a Buy rating from Jefferies
MD
09/14COMPUGROUP MEDICAL :  Medical announces medium-term targets for EBITDA-margin for the firs..
PU
More news
Analyst Recommendations on COMPUGROUP MEDICAL SOCIETAS EUROPAEA
More recommendations
Financials
Sales 2021 1 021 M 1 185 M 1 185 M
Net income 2021 81,8 M 94,9 M 94,9 M
Net Debt 2021 504 M 584 M 584 M
P/E ratio 2021 46,7x
Yield 2021 0,80%
Capitalization 3 752 M 4 353 M 4 352 M
EV / Sales 2021 4,17x
EV / Sales 2022 3,87x
Nbr of Employees 8 030
Free-Float 48,8%
Chart COMPUGROUP MEDICAL SOCIETAS EUROPAEA
Duration : Period :
CompuGroup Medical Societas Europaea Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends COMPUGROUP MEDICAL SOCIETAS EUROPAEA
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 71,15 €
Average target price 84,30 €
Spread / Average Target 18,5%
EPS Revisions
Managers and Directors
Dirk Wössner Chairman-Management Board & CEO
Michael Rauch Chief Financial Officer
Philipp von Ilberg Chairman-Supervisory Board
Frank Brecher Chief Technology Officer
Sven Thomas Müller Vice Chairman & Chief Information Officer
Sector and Competitors
1st jan.Capi. (M$)
COMPUGROUP MEDICAL SOCIETAS EUROPAEA-12.91%4 353
ORACLE CORPORATION47.29%260 602
SAP SE17.78%172 804
SERVICENOW, INC.20.48%131 399
DOCUSIGN, INC.17.17%51 239
HUBSPOT, INC.99.50%37 176